Zealand Pharma A/s

(OTC) ZLDPF

Current Price$47.37

Market Cap$3.35B

Since IPO (2012)+277%

5 Year+45%

1 Year-33%

1 Month+6%

Zealand Pharma A/s Financials at a Glance

Market Cap

$3.35B

Revenue (TTM)

$9.21B

Net Income (TTM)

$6.46B

EPS (TTM)

$13.64

P/E Ratio

3.40

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$47.37

Volume

2,318

Open

$49.75

Price

$47.37

Volume

2,318

Open

$49.75

Previous Close

$47.37

Daily Range

$47.37 - $49.75

52-Week Range

$35.93 - $83.12

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$47.37

Volume

2,318

Open

$49.75

Previous Close

$47.37

Daily Range

$47.37 - $49.75

52-Week Range

$35.93 - $83.12

ZLDPF News

Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio

David Jagielski, CPAJul 5, 2024

A team of scientists reviewing results in a lab.

Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss Stock.

David Jagielski, CPAMar 14, 2024

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zealand Pharma A/s

Industry

Biotechnology

Sector

Health Care

Employees

481

CEO

Adam Sinding Steensberg, MD, MBA

Website

www.zealandpharma.com

Headquarters

Copenhagen, 2860, DK

ZLDPF Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

76%

Net Income Margin

70%

Return on Equity

56%

Return on Capital

44%

Return on Assets

39%

Earnings Yield

29.41%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.35B

Shares Outstanding

70.62M

Volume

2.32K

Avg. Volume

2.85K

Financials (TTM)

Gross Profit

$9.17B

Operating Income

$7.14B

EBITDA

$7.17B

Operating Cash Flow

$6.52B

Capital Expenditure

$33.29M

Free Cash Flow

$6.48B

Cash & ST Invst.

$15.07B

Total Debt

$484.88M

Zealand Pharma A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$68.76M

+659.3%

Gross Profit

$60.80M

+603.0%

Gross Margin

88.42%

N/A

Market Cap

$3.35B

N/A

Market Cap/Employee

$8.69M

N/A

Employees

385

N/A

Net Income

$378.26M

-30.0%

EBITDA

$501.51M

-81.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$14.59B

+86.2%

Accounts Receivable

$318.96M

+129.5%

Inventory

$0.00

-100.0%

Long Term Debt

$462.30M

+23.0%

Short Term Debt

$22.58M

+40.8%

Return on Assets

39.21%

N/A

Return on Invested Capital

44.06%

N/A

Free Cash Flow

$1.06B

-476.3%

Operating Cash Flow

$1.04B

-476.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CAMRFCamurus AB (publ)

CAMRFCamurus AB (publ)$63.30+0.00%

HKMPFHikma Pharmaceuticals PLC

HKMPFHikma Pharmaceuticals PLC$18.10+0.00%

HKMPYHikma Pharmaceuticals PLC

HKMPYHikma Pharmaceuticals PLC$37.21+0.00%

AKBLFALK-Abelló A/S

AKBLFALK-Abelló A/S$35.55+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$99.62+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About ZLDPF

What is the current price of Zealand Pharma A/s?

Zealand Pharma A/s is trading at $47.37 per share.

What is the 52-week range for Zealand Pharma A/s?

Over the past 52 weeks, Zealand Pharma A/s has traded between $35.93 and $83.12.

How much debt does Zealand Pharma A/s have?

As of the most recent reporting period, Zealand Pharma A/s reported total debt of $63.80M.

How much cash does Zealand Pharma A/s have on hand?

Zealand Pharma A/s reported $719.63M in cash and cash equivalents in its most recent financial results.

What is Zealand Pharma A/s’s dividend yield?

Zealand Pharma A/s does not currently have a dividend yield.

Zealand Pharma A/s

Zealand Pharma A/s Financials at a Glance

ZLDPF News

2 Weight Loss Stocks That Are Screaming Buys in December

GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom

This GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its Money

This Rising Biotech Is a Fantastic Weight-Loss Stock to Buy Now

Missed Out on Eli Lilly? This Much Smaller Biotech Has 2 Promising Weight Loss Assets in its Portfolio

Missed Out on Novo Nordisk? This Much Smaller Danish Biotech Could Be the Next Hot Weight-Loss Stock.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Zealand Pharma A/s

ZLDPF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Zealand Pharma A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ZLDPF

What is the current price of Zealand Pharma A/s?

What is the 52-week range for Zealand Pharma A/s?

How much debt does Zealand Pharma A/s have?

How much cash does Zealand Pharma A/s have on hand?

What is Zealand Pharma A/s’s dividend yield?

Premium Investing Services